Antibody responses after inactivated influenza vaccine in young children

Peter F Wright1, Edith Sannella, Jian R Shi

  • 1Department of Pediatrics, Vanderbilt School of Medicine, Nashville, TN, USA. peter.wright@vanderbilt.edu

Insights

Antibody responses to trivalent inactivated influenza vaccine (TIV) in young children are sustained for months. This suggests protection throughout the influenza season following fall vaccination.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics

Background:

  • Antibody response duration and frequency after trivalent inactivated influenza vaccine (TIV) in young children are not well-defined.
  • Expanded TIV recommendations for children aged 6 months to 5 years highlight the need for this data.

Purpose of the Study:

  • To define the frequency and duration of antibody responses following TIV in young children.
  • To assess the durability of immune responses in relation to the influenza season.

Main Methods:

  • Forty-three children aged 6-23 months received TIV.
  • Antibody responses were measured using hemagglutination inhibition (HAI) and neutralization assays.
  • Antibody decay and duration were analyzed using sequential sera.

Main Results:

  • Four-fold HAI rises were observed in 72% (H3N2), 92% (H1N1), and 60% (Influenza B) of naive children after two TIV doses.
  • Antibody half-life (t1/2) was approximately 126 days for H1N1 and 258 days for H3N2.
  • Microneutralization assay results correlated well with HAI findings.

Conclusions:

  • While not all children achieved protective titers, antibody half-life suggests sustained immune responses.
  • Children vaccinated in the fall likely maintain protective antibody levels throughout the influenza season.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Cross-reactivity00:42

Cross-reactivity

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...